NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -89.4% | 3,017 | -42.5% | 0.00% | -100.0% |
| Q3 2021 | $94,000 | -65.4% | 5,248 | -66.9% | 0.00% | -66.7% |
| Q2 2021 | $272,000 | +13500.0% | 15,849 | +11553.7% | 0.01% | – |
| Q4 2020 | $2,000 | -99.6% | 136 | -99.4% | 0.00% | -100.0% |
| Q2 2020 | $489,000 | +270.5% | 21,131 | +192.6% | 0.05% | +42.1% |
| Q3 2019 | $132,000 | +1785.7% | 7,222 | +3212.8% | 0.04% | +1166.7% |
| Q1 2019 | $7,000 | -30.0% | 218 | +36.2% | 0.00% | 0.0% |
| Q3 2018 | $10,000 | -52.4% | 160 | -18.4% | 0.00% | -72.7% |
| Q1 2018 | $21,000 | +200.0% | 196 | -51.0% | 0.01% | +175.0% |
| Q3 2016 | $7,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |